/PRNewswire/ FibroBiologics, a clinical-stage company focused on the development of fibroblast cell-based therapeutics for chronic diseases, today announced.
/PRNewswire/ FibroBiologics, a clinical-stage company developing fibroblast cell-based therapeutics for chronic diseases, today introduced its scientific.
Preeminent scientists join FibroBiologics to provide input for the growing clinical pipeline of cell therapies HOUSTON, Dec. 15, 2021 /PRNewswire/ FibroBiologics, a clinical-stage